The relationship between oxidative stress and neuronal cell death has been suggested for many years. To understand the influence of oxidative stress on neuronal cell death, we investigated the influence of oxidative stress on DEV cells, a human glial cell line. Using enterovirus infection and/or malnutrition to induce oxidative stress, our results demonstrate that those stressors severely influence the antioxidant defense system in DEV cells. Although the expression of mitochondrial manganese superoxide dismutase (MnSOD) in DEV cells was significantly increased in acute infection with viral and nutritional stress, in persistent infection and nutritional stress, the expression of the MnSOD was drastically downregulated. We believe that this downregulation of MnSOD expression in the chronic stress model is due to repression of antioxidant defense. The downregulation of the MnSOD expression may lead to an increase of free-radical production and thus explain why the cells in the chronic stress model were more vulnerable to other oxidative stress influences. The vulnerability of DEV cells to additional stress factors resulted in progressive cell death, which may be analogous to the cell death in neurodegenerative diseases.
JennerP. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology47: S161–S170, 1996.
3.
JennerP. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord1: 24–34, 1998.
4.
MarkesberyWR. The role of oxidative stress in Alzheimer disease. Arch Neurol56: 1449–1452, 1999.
5.
McGrathLT, McGleenonBM, BrennanS, McCollD, McIlroyS, PassmoreAP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. Q J Med94: 485–490, 2001.
6.
KangJH, EumWS. Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutants. Biochim Biophys Acta1524(2–3):162–170, 2000.
7.
HallerJ, WeggemansRM, FerryM, and GuigozY. Mental health: minimental state examination and geriatric depression score of elderly Europeans in the SENECA study of 1993. Eur J Clin Nutr50(Suppl 2):S112–S116, 1996.
8.
RizzardiniM, LupiM, BernasconiS, MangoliniA, CantoniL. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J Neurol Sci207(1–2):51–58, 2003.
9.
De la MonteSM, ChicheJD, von dem BusscheA, SanyalS, LahousseSA, JanssensSP, BlochKD. Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: relevance to Alzheimer's-type neurodegeneration. Lab Invest83: 287–298, 2003.
10.
BealMF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol38: 357–366, 1995.
11.
HalliwellB, GutteridgeJM. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum Toxicol7(1):7–13, 1988.
McCormickML, OberleyTD, ElwellJH, OberleyLW, SunY, LiJJ. Superoxide dismutase and catalase levels during estrogen-induced renal tumorigenesis, in renal tumors and their autonomous variants in the Syrian hamster. Carcinogenesis12(6):977–983, 1991.
14.
TreitingerA, SpadaC, VerdiJC, MirandaAF, OliveiraOV, SilveiraMV, MorielP, AbdallaDS. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest30(5):454–459, 2000.
15.
ChoiSI, JuWK, ChoiE, KimJ, LeaHZ, CarpRI, WisniewskiHM, KimYS. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol (Berl)96(3):279–286, 1998.
WilliamsMD, Van RemmenH, ConradCC, HuangTT, EpsteinCJ, RichardsonA. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem273(43):28510–28515, 1998.
18.
Van RemmenH, WilliamsMD, GuoZ, EstlackL, YangH, CarlsonEJ, EpsteinCJ, HuangTT, RichardsonA. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol281(3):H1422–H1432, 2001.
19.
CermelliC, VincetiM, ScaltritiE, BazzaniE, BerettiF, VivoliG, PortolaniM. Selenite inhibition of Coxsackie virus B5 replication: implications on the etiology of Keshan disease. J Trace Elem Med Biol16(1):41–46, 2002.
20.
De la FuenteJ, HidalgoY, OchagaviaME, MuzioV, RodriguezMP. Analysis of enterovirus sequences recovered from the cerebrospinal fluid of patients with epidemic neuropathy. Ann Trop Med Parasitol93(2):153–161, 1999.
21.
RighthandVF. Tramsission of viral persistence by transfection of human cultured cells with RNA of a persistent strain of echovirus 6. Microb Pathog1: 57–65, 1991.
22.
GiraudonP, DufayN, HardinH, ReboulA, TardyM, BelinMF. Differentiation of a medulloblastoma cell line towards an astrocytic lineage using the human T-lymphotropic retrovirus-1. Neuroscience52: 1069–1079, 1993.
23.
JenningsMT, JenningsDL, EbrahimSA, JohnsonMD, Turc-CarelC, PhilipT, PhilipI, LaprasC, ShapiroJR. In vitro karyotypic and immunophenotypic characterization of primitive neuro-ectodermal tumors: similarities to malignant gliomas. Eur J Cancer28: 762–766, 1992.
24.
ReedLJ, MuenchH. A simple method of estimating fifty percent endpoints. Am J Hyg27: 493–497, 1938.
25.
CalabreseV, BatesTE, StellaAM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem Res25(9–10):1315–1341, 2000.
CastellaniR, HiraiK, AlievG, DrewKL, NunomuraA, TakedaA, CashAD, ObrenovichME, PerryG, SmithMA. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res70(3):357–360, 2002.
28.
Di MonteDA, ChanP, SandyMS. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage?Ann Neurol32(Suppl):S111–S115, 1992.
29.
BehlC. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol57: 301–323, 1999.
30.
SchapiraAH. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol9(4):260–264, 1996.
31.
FloresSC, MareckiJC, HarperKP, BoseSK, NelsonSK, McCordJM. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci U S A90(16):7632–7636, 1993.
32.
LevanderOA, BeckMA. Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol Trace Elem Res56(1):5–21, 1997.
33.
BeckMA. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. J Nutr127(5 Suppl):966S–970S, 1997.
34.
XieB, ZhouJF, LuQ, LiCJ, ChenP. Oxidative stress in patients with acute coxsackie virus myocarditis. Biomed Environ Sci15(1):48–57, 2002.
35.
AkaikeT, AndoM, OdaT, DoiT, IjiriS, ArakiS, MaedaH. Dependence on 02- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest85(3):739–745, 1990.
36.
KameokaM, KimuraT, IkutaK. Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission. FEBS Lett331(1–2):182–186, 1993.
37.
DandriM, BurdaMR, BurkleA, ZuckermanDM, WillH, RoglerCE, GretenH, PetersenJ. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology35(1):217–223, 2002.
38.
CopinJC, GascheY, ChanPH. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic Biol Med28(10):1571–1576, 2001.
39.
MelovS, CoskunP, PatelM, TuinstraR, CottrellB, JunAS, ZastawnyTH, DizdarogluM, GoodmanSI, HuangTT, MiziorkoH, EpsteinCJ, WallaceDC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A96(3):846–851, 1999.
40.
Van LoonAP, Pesold-HurtB, SchatzG. A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci U S A83(11):3820–3824, 1986.
